Prostanoids are indicated in the treatment of peripheral arterial disease (PAD). Available trials suggest that these compounds could reduce the symptoms of intermittent claudication, even though the quality of studies is poor. The present meta-analysis is aimed at verifying the effects of prostanoids on amputation rate and ulcer healing in patients with lower limb PAD.
Prostanoids in patients with peripheral arterial disease: A meta-analysis of placebo-controlled randomized clinical trials / Vitale, Valentina; Monami, Matteo; Mannucci, Edoardo. - In: JOURNAL OF DIABETES AND ITS COMPLICATIONS. - ISSN 1056-8727. - ELETTRONICO. - (2015), pp. ...-.... [10.1016/j.jdiacomp.2015.09.006]
Prostanoids in patients with peripheral arterial disease: A meta-analysis of placebo-controlled randomized clinical trials
MANNUCCI, EDOARDO
2015
Abstract
Prostanoids are indicated in the treatment of peripheral arterial disease (PAD). Available trials suggest that these compounds could reduce the symptoms of intermittent claudication, even though the quality of studies is poor. The present meta-analysis is aimed at verifying the effects of prostanoids on amputation rate and ulcer healing in patients with lower limb PAD.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
